---
figid: PMC4822554__kmco-03-02-1132120-g001
figtitle: Glucose promotes tumor growth by activating lipid synthesis and uptake upon
  N-glycosylation of SCAP
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4822554
filename: kmco-03-02-1132120-g001.jpg
figlink: /pmc/articles/PMC4822554/figure/f0001/
number: F1
caption: Glucose promotes tumor growth by activating lipid synthesis and uptake upon
  N-glycosylation of SCAP. Glucose-mediated N-glycosylation of SCAP promotes the trafficking
  of SCAP/SREBP from the ER to the Golgi, leading to subsequent SREBP activation.
  SREBP acts as a transcription factor to enhance the expression of lipogenesis genes
  and LDLR, thereby increasing levels of cellular lipids to support tumor growth.
  Oncogenic EGFR/PI3K/Akt signaling upregulates the glucose uptake-SCAP N-glycosylation-SREBP
  activation pathway to promote tumor growth. EGFR, epidermal growth factor receptor;
  ER, endoplasmic reticulum; LDLR, low-density lipoprotein receptor; PI3K, phosphoinositide
  3-kinase; UDP-GlcNAc, uridine diphosphate (UDP)-N-acetylglucosamine (GlcNAc); TCA,
  tricarboxylic acid.
papertitle: SCAP links glucose to lipid metabolism in cancer cells.
reftext: Deliang Guo. Mol Cell Oncol. 2016 Mar;3(2):e1132120.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9251051
figid_alias: PMC4822554__F1
figtype: Figure
redirect_from: /figures/PMC4822554__F1
ndex: c3fcb59d-dea5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4822554__kmco-03-02-1132120-g001.html
  '@type': Dataset
  description: Glucose promotes tumor growth by activating lipid synthesis and uptake
    upon N-glycosylation of SCAP. Glucose-mediated N-glycosylation of SCAP promotes
    the trafficking of SCAP/SREBP from the ER to the Golgi, leading to subsequent
    SREBP activation. SREBP acts as a transcription factor to enhance the expression
    of lipogenesis genes and LDLR, thereby increasing levels of cellular lipids to
    support tumor growth. Oncogenic EGFR/PI3K/Akt signaling upregulates the glucose
    uptake-SCAP N-glycosylation-SREBP activation pathway to promote tumor growth.
    EGFR, epidermal growth factor receptor; ER, endoplasmic reticulum; LDLR, low-density
    lipoprotein receptor; PI3K, phosphoinositide 3-kinase; UDP-GlcNAc, uridine diphosphate
    (UDP)-N-acetylglucosamine (GlcNAc); TCA, tricarboxylic acid.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Egfr
  - SCAP
  - bmm
  - SREBP
  - LRP1
  - modSP
  - LpR2
  - mgl
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - EGFR
  - SH2D2A
  - LDLR
  - Fructose
  - Glucose
  - Pyruvate
  - UDP
  - Lactate
---
